Publication:
Anakinra Treatment in a Patient With End-Stage Renal Failure Due to FMF-Associated Amyloidosis: 5.5 Years of Experience

dc.contributor.authorCengiz, Ahmet Kivanc
dc.date.accessioned2025-12-11T00:32:59Z
dc.date.issued2024
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Cengiz, Ahmet Kivanc] Ondokuz Mayis Univ, Fac Med, Dept Phys Med & Rehabil, Div Rheumatol, Samsun, Turkiyeen_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue10en_US
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://hdl.handle.net/20.500.12712/37303
dc.identifier.volume42en_US
dc.identifier.wosWOS:001344024100055
dc.identifier.wosqualityQ2
dc.institutionauthorCengiz, Ahmet Kivanc
dc.language.isoenen_US
dc.publisherClinical & Experimental Rheumatologyen_US
dc.relation.ispartofClinical and Experimental Rheumatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAnakinra Treatment in a Patient With End-Stage Renal Failure Due to FMF-Associated Amyloidosis: 5.5 Years of Experienceen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files